Products 1306760-87-1

CAS 1306760-87-1 appears in our catalog under these names: Ozanimod, Ozanimod, >95% (HPLC), Ozanimod (RPC1063), Ozanimod/ 99.74% (existing batch purity), Ozanimod 99%. Offered by: Chemat Brand, TRC, GLPBio, TargetMol, Biosynth. Available pack sizes: on request, 10mg, 1mg, 2,5mg, 25mg, 5mg, 50mg, 100mg.

Ozanimod
Chemat Brand, Biosynth
  • size: on request, 0,1g, 0,25g, 0,5g
  • Variants: 4
View product
Ozanimod, >95% (HPLC)
TRC
  • size: 10mg, 1mg, 2,5mg
  • Variants: 3
View product
Ozanimod (RPC1063)
GLPBio
  • size: 25mg, 5mg
  • Variants: 2
from 868.51
View product
Ozanimod/ 99.74% (existing batch purity)
TargetMol
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 8
from 452.11
View product
Ozanimod 99%
Ambeed
  • size: 1mg, 2mg, 5mg, 10mg
  • Variants: 8
from 170.12
View product
(S)-5-(3-(1-((2-Hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile, 99%, 99%
Chemat
  • size: 1mg, 2mg, 5mg, 10mg
  • Variants: 8
from 112.40
View product
Ozanimod, 99.98%
MedChemExpress
  • size: 5 mg, 10mM/1mL, 10 mg, 100 mg
  • Variants: 6
from 695.86
View product
Ozanimod (Standard)
MedChemExpress
  • size: 10 mg, 100 mg, 25 mg, 5 mg
  • Variants: 5
from 1559.64
View product
OZANIMOD, 99%
Fluorochem
  • size: 5mg, 10mg, 50mg, 100mg
  • Variants: 6
from 200.99
View product
Structural formula: {0} (CAS {1})

Ozanimod is a sphingosine 1-phosphate receptor modulator being studied to treat Multiple Sclerosis (MS) and inflammatory bowel disease (IBD).

Source: ChEBI

Identity
Molecular formulaC23H24N4O3
Molecular weight404.5 g/mol
IUPAC name5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile
InChIKeyXRVDGNKRPOAQTN-FQEVSTJZSA-N
SMILESCC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CC[C@@H](C4=CC=C3)NCCO)C#N

Computed by PubChem (NCBI)

Synonyms: Ozanimod, Ozanimodum, Ozanimod (RPC1063), Ozanimod [INN], Ozanimod [USAN:INN], Ozanimod (Standard), OZANIMOD [USAN], Ozanimod; RPC1063, Ozanimod (USAN/INN), OZANIMOD [MI]
Related forms of this compound
5-[3-[(1R)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile C23H24N4O3
Isomers (same molecular formula)
ethyl 4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzoate C23H24N4O3
(4S)-4-(4-cyano-2-methoxyphenyl)-5-(cyclopropylmethoxy)-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide C23H24N4O3
(4S)-4-(4-cyano-2-methoxyphenyl)-5-cyclobutyloxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide C23H24N4O3
(4R)-4-(4-cyano-2-methoxyphenyl)-5-(cyclopropylmethoxy)-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide C23H24N4O3
(4R)-4-(4-cyano-2-methoxyphenyl)-5-cyclobutyloxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide C23H24N4O3
N-(2-methylphenyl)-2-[5-(oxan-4-yl)-1,2,4-oxadiazol-3-yl]-2,3-dihydroindole-1-carboxamide C23H24N4O3
ethyl 3-amino-2-[[4-[2-(N'-hydroxycarbamimidoyl)phenyl]phenyl]methylamino]benzoate C23H24N4O3